# Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial

> **NCT02022098** · NA · COMPLETED · sponsor: **Debiopharm International SA** · enrollment: 144 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** Radiotherapy
- **DRUG:** Debio 1143
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02022098
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2020-07
- **Final completion:** 2022-04-28
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022098, "Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02022098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*